Literature DB >> 1942954

Hyperlipidemia in acute hemolysis.

W Druml1, G Grimm, A N Laggner, B Schneeweiss, K Lenz.   

Abstract

In 27 (78%) of 36 patients with massive hemolysis (defined as a fall in hematocrit of more than 12% within 12 h due to intravascular red cell destruction), hypertriglyceridemia (plasma triglycerides greater than 175 mg/dl) was present or appeared within two days after the hemolytic crisis. Eighteen subjects with triglycerides exceeding 300 mg/dl (peak 516 +/- 39 mg/dl) were further analyzed. The development of hyperlipidemia was independent of the etiology of hemolysis (microangiopathic hemolytic disease 7, toxicemia 3, parainfectious complications 3, autoimmune hemolysis 2, glucose-6-phosphate dehydrogenase deficiency 2). Factors known to increase plasma triglycerides, such as shock, infections, or pancreatitis, were present in only a few cases. Hemolysis-associated complications were activation of intravascular coagulation (16), coma (13), acute renal failure (13), and respiratory insufficiency (5), organ dysfunctions indicating diffuse microvascular injury. Plasma triglycerides fell within a few days if the cause of red cell destruction was eliminated. In 5 of the 8 patients presenting with triglycerides below 175 mg/dl, severe hepatic dysfunction was present. We conclude that hemolysis causes transient hyperlipidemia, either directly by red cell destruction or indirectly by inducing intravascular coagulation, and possibly due to both increased triglyceride synthesis and decreased catabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1942954     DOI: 10.1007/bf01666827

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  16 in total

1.  Intravascular coagulation in hyperlipidemia.

Authors:  A C Carvalho; R S Lees; R A Vaillancourt; R B Cabral; R M Weinberg; R W Colman
Journal:  Thromb Res       Date:  1976-06       Impact factor: 3.944

2.  Hyperlipidemia in experimental disseminated intravascular coagulation.

Authors:  A N Whitaker; I Bunce; B R Knowles; E R Richardson
Journal:  J Trauma       Date:  1974-02

3.  Genesis of fat emboli.

Authors:  A J Watson
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1970

4.  Serum lipids in infection.

Authors:  J I Gallin; D Kaye; W M O'Leary
Journal:  N Engl J Med       Date:  1969-11-13       Impact factor: 91.245

5.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

6.  Plasma triglycerides and cholesterol in diabetic ketosis.

Authors:  M Fulop; H A Eder
Journal:  Arch Intern Med       Date:  1989-09

7.  Activation of the alternative pathway of human complement by haemoglobin.

Authors:  W A Wilson; E J Thomas
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

8.  Multiple cytokines stimulate hepatic lipid synthesis in vivo.

Authors:  K R Feingold; M Soued; M K Serio; A H Moser; C A Dinarello; C Grunfeld
Journal:  Endocrinology       Date:  1989-07       Impact factor: 4.736

9.  Hemoglobin. A biologic fenton reagent.

Authors:  S M Sadrzadeh; E Graf; S S Panter; P E Hallaway; J W Eaton
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.157

10.  Acute hemolytic transfusion reactions--a fresh look at pathogenesis and considerations regarding therapy.

Authors:  D Goldfinger
Journal:  Transfusion       Date:  1977 Mar-Apr       Impact factor: 3.157

View more
  7 in total

1.  Hypertriglyceridemia thalassemia syndrome: a report of 4 cases.

Authors:  Rachna Khera; Meeta Singh; Garima Goel; Parul Gupta; Tejinder Singh; A P Dubey
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-02       Impact factor: 0.900

2.  Hypertriglyceridemia Thalassemia Syndrome: Common Disease, Uncommon Association.

Authors:  Lipsa Das; Madhusudan Samprathi; Umesh Shukla; Debapriya Bandyopadhyay; Rashmi Ranjan Das
Journal:  Indian J Pediatr       Date:  2016-03-03       Impact factor: 1.967

3.  What is this chocolate milk in my circuit? A cause of acute clotting of a continuous renal replacement circuit: Answers.

Authors:  Aadil Kakajiwala; Kathleen Chiotos; Julie Brothers; April Lederman; Sandra Amaral
Journal:  Pediatr Nephrol       Date:  2016-01-27       Impact factor: 3.714

4.  Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver Disease.

Authors:  D C McLaughlin; D C Fang; B A Nolot; P K Guru
Journal:  Indian J Nephrol       Date:  2018 Jul-Aug

5. 

Authors:  L Thomas
Journal:  EJIFCC       Date:  2002-06-10

6. 

Authors:  L Thomas
Journal:  EJIFCC       Date:  2002-06-10

7.  Haemolysis as Influence & Interference Factor.

Authors:  L Thomas
Journal:  EJIFCC       Date:  2002-06-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.